Table 1 Demographics of nominal group participants (n = 44)
N (%), unless otherwise specified | |
|---|---|
Age in years, mean (SD) | 61.7 (12.2) |
Sex, male (%) | 22 (50%) |
Race/ethnicity | |
White | 14 (32%) |
African-American | 30 (68%) |
Education level | |
High School graduate | 13 (29%) |
Some college or technical/vocational training | 10 (23%) |
College Degree: Bachelors and beyond | 21 (48%) |
Marital Status | |
Divorced | 8 (18%) |
Married | 21 (48%) |
Separated | 3 (7%) |
Single | 6 (14%) |
Widowed | 6 (14%) |
Employment status | |
Employed | 4 (9%) |
Homemaker | 4 (9%) |
Out of work | 5 (11%) |
Retired | 19 (43%) |
Self-employed | 3 (7%) |
Unable to work | 9 (20%) |
Disease duration in yearsa, mean (SD) | 11.8 (11.8) |
Current medications to treat goutb | |
Allopurinol (with or without prednisone) | 16 (36%) |
Allopurinol + colchicine (with or without pain medication) | 17 (41%) |
Allopurinol + colchicine + prednisone (with or without pain medication) | 1 (2%) |
Pain medications (NSAIDs or narcotics) with or without prednisone | 2 (5%) |
Allopurinol + febuxostat | 1 (2%) |
Febuxostat (with or without prednisone) | 3 (8%) |
Febuxostat + colchicine + prednisone + narcotics | 2 (5%) |
None | 1 (2%) |
Current use of natural supplements for goutb | |
None | 23 (53%) |
Cherry extract or concentrate | 3 (7%) |
Cherry juice | 10 (23%) |
Multivitamin or Vitamin B or Vitamin D | 7 (17%) |
Number of gout flares in the last 6 monthsb | |
None | 17 (39%) |
One | 3 (8%) |
Two | 10 (23%) |
Three to five | 5 (12%) |
Six or more | 8 (18%) |